Treating Life-Threatening Bleedings: Development of Recombinant
Coagulation Factor VIIa provides a comprehensive understanding of
the first new drug within the area of hemostasis, describing a new
mechanism of action that has resulted in a modified concept of the
whole hemostasis mechanism. As the treatment of life-threatening
bleedings is a serious challenge for clinicians, this powerful and
historic case study presents a detailed roadmap on how a new
medicine can be developed, stressing the interaction between
science and clinical work. The book stresses the importance of
patient care in the learning process and provides new ideas on how
to approach diseases and their treatment. Users will find a real
world example that will act as a timely resource for those learning
about, or engaged in, performing and supervising research across
the biomedical sciences.
General
| Imprint: |
Academic Press Inc
|
| Country of origin: |
United States |
| Release date: |
July 2017 |
| First published: |
2017 |
| Authors: |
Ulla Hedner
|
| Dimensions: |
229 x 152 x 14mm (L x W x T) |
| Format: |
Paperback
|
| Pages: |
214 |
| ISBN-13: |
978-0-12-812439-0 |
| Categories: |
Books >
Medicine >
Clinical & internal medicine >
Haematology
|
| LSN: |
0-12-812439-3 |
| Barcode: |
9780128124390 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
